RHÖN-KLINIKUM AG:企業の戦略・SWOT・財務情報

◆英語タイトル:RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1945
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

RHÖN-KLINIKUM AG – Strategy, SWOT and Corporate Finance Report
Summary

RHÖN-KLINIKUM AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

RHON-KLINIKUM AG (RHON-KLINIKUM) is one of the largest providers of health care services in Germany and uses scientifically founded therapy procedures and stat-of-the-art medical technology to treat its patients. The company also focuses on research and development of medical technology through its various innovations programme, and seeks to treat patients by providing them the access to latest medical technology. The company has operations across Germany and it is headquartered in Bad Neustadt a. d. Saale, Germany.

Scope

- Detailed information on RHÖN-KLINIKUM AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting RHÖN-KLINIKUM AG in the form of a SWOT analysis
- An in-depth view of the business model of RHÖN-KLINIKUM AG including a breakdown and examination of key business segments
- Intelligence on RHÖN-KLINIKUM AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about RHÖN-KLINIKUM AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of RHÖN-KLINIKUM AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess RHÖN-KLINIKUM AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on RHÖN-KLINIKUM AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
RHÖN-KLINIKUM AG: Company Overview 9
RHÖN-KLINIKUM AG: Overview and Key Facts 9
RHÖN-KLINIKUM AG: Overview 9
RHÖN-KLINIKUM AG: Key Facts 9
RHÖN-KLINIKUM AG: Key Employees 11
RHÖN-KLINIKUM AG: Key Employee Biographies 12
RHÖN-KLINIKUM AG: Major Products and Services 13
RHÖN-KLINIKUM AG: Company History 14
RHÖN-KLINIKUM AG: Key Competitors 16
RHÖN-KLINIKUM AG: Company Analysis 17
RHÖN-KLINIKUM AG: Business Description 17
RHÖN-KLINIKUM AG: SWOT Analysis 18
RHÖN-KLINIKUM AG: SWOT Overview 18
RHÖN-KLINIKUM AG: Strengths 18
RHÖN-KLINIKUM AG: Weaknesses 18
RHÖN-KLINIKUM AG: Opportunities 19
RHÖN-KLINIKUM AG: Threats 19
RHÖN-KLINIKUM AG: Corporate Financial Deals Activity 21
RHÖN-KLINIKUM AG: Financial Deals Overview 21
RHÖN-KLINIKUM AG: Targets and Partners 22
RHÖN-KLINIKUM AG: Top Deals 2014 – 2018YTD* 23
RHÖN-KLINIKUM AG: Mergers and Acquisitions 24
RHÖN-KLINIKUM AG: Recent Developments 25
RHÖN-KLINIKUM AG: News and Events Summary 25
RHÖN-KLINIKUM AG: Contracts 26
RHÖN-KLINIKUM AG: Corporate Governance 28
RHÖN-KLINIKUM AG: Financial Performance 28
RHÖN-KLINIKUM AG: Strategy and Operations 29
Appendix 30
Contact Us 30
Methodology 30
About MarketLine 31

List of Tables
Table 1: RHÖN-KLINIKUM AG: Key Facts
Table 2: RHÖN-KLINIKUM AG: Key Employees
Table 3: RHÖN-KLINIKUM AG: Key Competitors
Table 4: RHÖN-KLINIKUM AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 5: RHÖN-KLINIKUM AG: Targets and Partners
Table 6: RHÖN-KLINIKUM AG: Top Deals 2014 - 2018YTD*
Table 7: RHÖN-KLINIKUM AG: M&A Volume and Value Trend (2014 - YTD*2018)
Table 8: RHÖN-KLINIKUM AG: News and Events Summary
Table 9: RHÖN-KLINIKUM AG: Contracts
Table 10: RHÖN-KLINIKUM AG: Corporate Governance
Table 11: RHÖN-KLINIKUM AG: Financial Performance
Table 12: RHÖN-KLINIKUM AG: Strategy and Operations

List of Figures
Figure 1: RHÖN-KLINIKUM AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: RHÖN-KLINIKUM AG: M&A Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[RHÖN-KLINIKUM AG:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Toma Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Toma Biosciences Inc (Toma Biosciences) is a provider of genome sequencing solutions. The company launched TOMA OS-Seq cancer assay to laboratories and researchers for the changes in tumors. Its products include reagent kits that are developed to detect genomic changes in cancer and TOMA OS- …
  • Land O’Lakes, Inc.:企業の戦略・SWOT・財務情報
    Land O'Lakes, Inc. - Strategy, SWOT and Corporate Finance Report Summary Land O'Lakes, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Synthos SA:企業の戦略的SWOT分析
    Synthos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Federal Grid Company of Unified Energy System (FEES):企業の財務・戦略的SWOT分析
    Federal Grid Company of Unified Energy System (FEES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Casey’s General Stores, Inc. (CASY):企業の財務・戦略的SWOT分析
    Casey's General Stores, Inc. (CASY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • JD.com Inc:企業の戦略・SWOT・財務情報
    JD.com Inc - Strategy, SWOT and Corporate Finance Report Summary JD.com Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cosan S.A. Industria e Comercio (CSAN3):企業の財務・戦略的SWOT分析
    Cosan S.A. Industria e Comercio (CSAN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Diamondback Energy Inc (FANG):石油・ガス:M&Aディール及び事業提携情報
    Summary Diamondback Energy Inc (Diamondback Energy) is an oil and gas company that offers exploration and development programs. The company acquires, develops, explores and exploits unconventional, onshore oil and natural gas reserves in Permian Basin in West Texas. It develops the reserves and prod …
  • viDA Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary viDA Therapeutics Inc (viDA) is a biopharmaceutical company that discovers, develops and commercializes novel and targeted therapeutics for the treatment of autoimmune and age-related chronic inflammatory diseases. The company’s lead product candidate include VTI-1002, is in a topical formul …
  • JGC Corporation (1963)-エネルギー分野:企業M&A・提携分析
    Summary JGC Corporation (JGC) is an engineering contracting company. It offers engineering, procurement and construction services for various engineering contracts and projects in the areas of oil and gas development, petroleum refining, natural gas processing, petrochemicals, clean energy and power …
  • Eureka Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Eureka Therapeutics Inc (Eureka Therapeutics) is a clinical stage biotechnology company which focuses on the development of novel T cell immunotherapies for the treatment of solid tumors. Its pipeline encompasses drug candidates for various indications such as liver cancer, hematological can …
  • Greencore Group Plc:企業の戦略・SWOT・財務情報
    Greencore Group Plc - Strategy, SWOT and Corporate Finance Report Summary Greencore Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tullow Oil Plc (TLW):企業の財務・戦略的SWOT分析
    Tullow Oil Plc (TLW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Catabasis Pharmaceuticals Inc (CATB):製薬・医療:M&Aディール及び事業提携情報
    Summary Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and ratio …
  • UPM-Kymmene Corporation (UPM):企業の財務・戦略的SWOT分析
    UPM-Kymmene Corporation (UPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Haemonetics Corp (HAE):医療機器:M&Aディール及び事業提携情報
    Summary Haemonetics Corp (Haemonetics) is a healthcare company that offers blood management technologies and software solutions. Its portfolio includes integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehensive suite o …
  • Sir Robert McAlpine Ltd:企業の戦略的SWOT分析
    Sir Robert McAlpine Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Astron Corporation Ltd (ATR):企業の財務・戦略的SWOT分析
    Astron Corporation Ltd (ATR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bioasis Technologies Inc (BTI):医療機器:M&Aディール及び事業提携情報
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆